3189 results for «565»
3189 results
Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation
28 Nov 2022 – From PCR London Valves 2022
Consult these presentations to learn more about the consequences of right ventricular pacing lead implantation on tricuspid valve function, the diagnosis and imaging assessment of lead-induced tricuspid regurgitation and the possible treatment options for patients with right ventricular pacing leads and significant tricuspid regurgitation.
Weird and wonderful!
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of cases presented during PCR LV 2022: endovascular treatment of aortic re-coarctation and giant aneurysm, percutaneous closure of a left ventricular pseudoaneurysm using transseptal approach, TAVI concomitant EVAR of distal aortic arch and closure of iatrogenic aorta-right ventricle fistula, and...
Mitral - Late-Breaking Trials and Innovations
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of late-breaking trials presented during PCR LV 2022: TENDyne European expeRience registry, CLASP IID trial, EXPAND G4, and much more!
Transcatheter mitral valve interventions: clinical outcomes 1
28 Nov 2022 – From PCR London Valves 2022
Consult this session on transcatheter mitral valve interventions to discover a selection of abstracts submitted during PCR London Valves 2022: one-year outcomes for transcatheter mitral repair from the MiCLASP study, the Edwards PASCAL transcatheter mitral valve repair system study, one-year outcomes of Tendyne TMVR treating symptomatic MR,...
Imaging for mitral valve interventions
28 Nov 2022 – From PCR London Valves 2022
Thanks to this PCR LV 2022 session, find out more about outcome of patients undergoing transcatheter edge-to-edge mitral valve repair with HFpEF diagnosis.
Valve-in-valve TAVI: Session 2
28 Nov 2022 – From PCR London Valves 2022
Consult this session on Valve-in-valve TAVI to discover a selection of cases presented during PCR LV 2022: valve-in-valve TAVR status post ascending aorta and aortic arch replacement, valve-in-valve and endovascular treatment of aortic dissection in a Marfan patient, valve-in-valve TAVR in a freestyle root 25 mm through a severely...
TAVI in patients at risk of coronary occlusion
28 Nov 2022 – From PCR London Valves 2022
Consult this session on TAVI in patients at risk of coronary occlusion to discover a selection of cases presented during PCR LV 2022: hyperacute obstruction of the left main artery due to calcium displacement during TAVR, cannulation technique for challenging coronary access following TAVI-in-TAVI, complex TAVI from...
Mitral: new devices and procedural refinements
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of cases regarding mitral new devices: transapical mitral valve implantation for treatment of symptomatic mitral valve disease, transcatheter edge-to-edge mitral valve repair for atrial functional mitral regurgitation, and much more!
Combined valve interventions
28 Nov 2022 – From PCR London Valves 2022
Among the very interesting cases presented in this PCR LV 2022 session, watch the 1st case of TMVR and TTVR in a patient with the use of dedicated investigational devices, simultaneous transcatheter mitral and tricuspid approach in a patient with dextrocardia, or simultaneous mitral valve-in-valve, tricuspid...
Mitral complications
28 Nov 2022 – From PCR London Valves 2022
Because we can all be confronted with unexpected complications, this session of PCR LV 2022 proposes to study 5 specific cases such as an early redo mitral transcatheter edge-to-edge repair after single leaflet detachment or an unexpected cause of worsening dyspnoea after edge-to-edge mitral repair.
Transcatheter mitral valve interventions: clinical outcomes 2
28 Nov 2022 – From PCR London Valves 2022
This PCR LV 2022 session will enable you to discover outcomes of transcatheter edge-to-edge MVR in patients with right ventricle dysfunction, TEER for MR early after myocardial infarction, or a predictive selection of patients for TMVR, among others!
TAVI: technical considerations
28 Nov 2022 – From PCR London Valves 2022
Consult this session on TAVI technical considerations to discover a selection of cases presented during PCR LV 2022: transseptal snaring as a bailout from valvuloplasty balloon entrapment within a self-expanding valve, severe thrombocytopenia and severe aortic stenosis, embolisation of a fully deployed Evolute valve due to chest...
TAVI complications: Session 3
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover how to manage various TAVI complications: complex iliofemoral artery dissection following TAVI, ruptured TAVI balloon, displacement of the transcatheter aortic valve prosthesis, and much more!
Rapid-fire abstracts: Session 5
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of right ventricular dysfunction on the outcomes of TAVI - Insights from nationwide database, impact of COVID-19 pandemic on TAVI activity: a worldwide registry, redo isolated tricuspid valve surgery - Prediction of...
Rapid-Fire clinical cases: Session 3
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of clinical cases presented during PCR LV 2022: tunnel stent technique as an alternative treatment for left main protection in valve-in-valve TAVI, coronary embolisation due to valve-in-valve aortic prothesis thrombosis, aortic prosthetic valve dysfunction due to endocarditis, and more!
Mitral edge-to-edge repair: surgical and transcatheter approaches - LIVE case
29 Nov 2022 – From PCR London Valves 2022
Learn from these 2 cases of primary mitral repair using percutaneous and surgical approaches:
- LIVE case - A 90-year-old male with history of LAD PCI 23 years ago and paroxysmal atrial fibrillation presents a primary mitral regurgitation (P2 prolapse) on mildly dilated LV and preserved LV function.
The operators...
Aortic stenosis and concomitant mitral valve disease
29 Nov 2022 – From PCR London Valves 2022
Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.
Rapid-fire abstracts: Session 6
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: hydrodynamic performance of ACURATE neo2 for valve-in-valve across different surgical bioprostheses, impact of leaflets splitting on coronary access after redo TAVI in failed supra-annular platforms, same-day discharge after TF and alternate access...
Rapid-fire abstracts: Session 7
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...
Mitral annular calcification - From diagnosis to treatment
29 Nov 2022 – From PCR London Valves 2022
Focus on mitral annular calcification: from diagnosis to treatment, learn more about the prevalence and clinical importance of MAC, understand the challenges of different therapeutic approaches and discover the current results and perspectives on transcatheter mitral valve implantation in patients with MAC.
